Systematic reviews on corona disease 2019 (COVID-19)
COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is very limited data available on almost all aspects of this disease.
We are refocussing our work to provide rapid systematic reviews on COVID-19. In the first place we will focus on risk factors for prognosis, risk factors for incidence and the effectiveness of new interventions.
We are looking for colleagues with experience in systematic reviews to help us, specifically those with expertise literature searching of pre-print journals and archives, critical appraisal and meta-analyses in stata.
If you are interested please contact m.zeegers@maastrichtuniversity.nl
Also read
-
How to make the best decision in the consulting room
Climate, costs, AI and social media all influence medical decision-making. How do we ensure GPs make the best decision for patients with as little negative impact on society as possible?
-
Results of the ‘We are the medicine’ awareness campaign: more knowledge of dementia prevention
The aim of the campaign was to make people more aware of the influence they themselves have on their risk of dementia. The initial results show that knowledge about risk factors has increased.
-
Better prospects for people with head and neck cancer
How can we improve diagnosis, treatment and monitoring of head and neck cancer? Francesco Missale studies this: from new microscopes and immunotherapy to tumour markers.
